Band purchase trend pre-judgment.

Band procurement is currently the most influential policy on the pharmaceutical industry, tape procurement will be how long, its ultimate goal is what is naturally become the industry's most concerned about the issue.
comprehensive current progress, relevant documents and the spirit of the leadership speech judgment, belt procurement will generally experience from exploration, normalization to full coverage of the three stages, the upcoming third batch of volume procurement, is the second stage that is the beginning of normalization.
. The exploration period so far, the volume procurement has experienced 4 plus 7, 4 plus 7 expansion and the second batch of tape procurement, such as 3 trial operation, and has achieved phased results.
"4 plus 7 pharmaceutical companies annual performance review: indicators, varieties, shares... 1, rules: and constantly improve.
from simple bidding to the second batch of preset ≮ 50%, 1.8 times ≯ and quotes as low as 0.1 yuan can be directly shortlisted and other conditions.
2, region: expanding. the
was expanded from 11 cities (4 plus 7) to 25 provinces (4 plus 7 expansion) and then nationwide (second batch).
3, variety: (1) category: constantly enriched.
from the medical insurance catalog varieties, extended to non-medical insurance varieties (such as the second batch of injection of yew alcohol (albumin binding type), Anlison tan tablets, Tadalafi tablets, etc., from the drug to the supply of consumables (such as Anhui, Jiangsu, Beijing-Tianjin-Hebei and other northern 9 provinces, such as the "3 plus 6" alliance for high-value consumables to carry on the volume procurement).
(2) dosage form: increasing.
mainly by oral often-release dosage form, gradually extended to injection, slow release of changrelease dosage form, oral disintegrating tablets and so on.
At the same time, in order to carry out more exploration, the State has also expanded to the local area to carry out the same volume procurement, and a clear division of labour, namely: (1) the state: responsible for the adoption of consistency evaluation of chemical drugs for band procurement.
(2) Place: The range of varieties purchased with volume is extended from over-rated chemical drugs to non-evaluated drugs, Chinese medicine and biological drugs.
"local belt quantity procurement, all-round analysis" 4, allow the number of selected manufacturers: increasing.
from the exclusive selection (4 plus 7) to 3 (4 plus 7 expansion), in order to take into account more overrated manufacturers, but also enlarged to 6 home selection (second batch).
5, procurement period: constantly extended.
extended from one year (4 plus 7) to 1-2 years (4 plus 7 expansion) and then to 2-3 years (second batch).
, normalization after nearly two years of exploration, the competent party has accumulated a wealth of experience, the volume of procurement has basically achieved from the exploration period to normalization and institutionalization of the leap.
the so-called normalization, that is, once the variety to achieve a certain competitive pattern (such as 3), with a certain competitive pattern of varieties to reach a certain number (e.g. 30) then automatically trigger the procurement mechanism, and no longer have to ask, but also no more batch, the third batch of collection is the beginning of normalization.
the so-called institutionalization, can be summarized by the following five: 1, adhere to the "belt volume" procurement, clear band rule 2, adhere to the market to find prices: the official only set the rules, enterprises voluntarily participate, independent quotation, competitive results.
3, adhere to improve the safeguards: including incentive and restraint mechanisms, emphasizing the responsibility of all parties, mobilize the enthusiasm of all parties to ensure the quality, supply, use, return of selected drugs.
, such as the just issued "National Health Insurance Bureau Ministry of Finance on the state-organized drug centralized procurement work of the health insurance fund balance retention guidance", is to take the amount of procurement after the reduction of drug costs and medical insurance payment budget fund difference as an incentive, return part to public medical institutions, thereby stimulating medical institutions to use the preferred varieties.
4, adhere to and improve the recruitment operation mechanism: that is, "national organizations, alliance recruitment, platform operation", the state is only responsible for the organization is not directly involved in recruitment, the main body of recruitment is the alliance.
provincial platform is the operational carrier of tender procurement, at the same time under the State Medical Insurance Bureau to set up a new national price recovery center, as the provincial platform of the higher guidance agency, co-ordination and service of the national recruitment.
5, promote the mechanism of the procurement cycle: clear trigger mechanism, avoid administrative willfulness, such as to achieve a certain market competition pattern of varieties to reach a certain number, that is, automatic trigger procurement mechanism.
three, full coverage should be harvested, do not leave dead ends, full coverage contains variety coverage and area coverage of two dimensions.
1, variety of the purchase of the amount not only from the drug to supplies, from the evaluation of drugs to the non-evaluated drugs, but also from the chemical drugs to expand to Chinese medicine and biological drugs, such as Qinghai Province and Zhejiang Jinhua City has been the amount of Chinese medicine procurement, Wuhan City also carried out a band procurement of insulin.
in addition, July 15-16, the State Health Insurance Administration also held a special symposium on biological products and the centralized procurement of traditional Chinese medicine, causing strong industry response, because Chinese medicine and biologic drugs accounted for half of the national pharmaceutical market, in 2018, the size of the chinese medicine and biological medicine market is 483.7 billion yuan and 262.2 billion yuan, of which Chinese medicine accounted for 31.5% of the country.
2, regional volume procurement from public hospitals, gradually extended to private hospitals, but also to further expand to retail pharmacies, such as June 29 in Zhejiang Province issued "on the issuance of Zhejiang Province to enhance the function of centralized drug procurement platform to promote the health insurance drug payment standards full coverage reform program" covers the health insurance fixed-point retail pharmacies.
2015, China's actual pharmaceutical companies in the sale of 3477, and the U.S. pharmaceutical market size is more than 4 times China's, but only more than 800 pharmaceutical companies, Japan is only 342, in addition, China's drug approval spending as many as 170,000, but the utilization rate of approval only 11%, and the U.S. approval utilization rate as high as 53%.
Figure 2.
through the comprehensive promotion of the volume of procurement, drug prices significantly reduced and maintained relative stability, patient burden greatly reduced, completely solve the false high drug prices, in order to achieve the 19th National Congress of the Communist Party of China proposed the "total elimination of medicine-based medicine" goal, while small, scattered, disorderly elimination (Figure 2), and finally achieve the State Council on November 29, 2019 The "Notice on a number of policy measures to further deepen the reform of the medical and health system with the centralized procurement and use of drugs as a breakthrough" issued by the Leading Group on Deepening Medical Reform sets out the goal of "promoting cross-regional and cross-ownership mergers and reorganization of pharmaceutical production and circulation enterprises, cultivating a number of large enterprise groups with international competitiveness, and accelerating the formation of a pattern of drug production and circulation with large-scale backbone enterprises as the main body and small and medium-sized enterprises as the supplement".
.